Dergiler / Medeniyet Medical Journal / 2018 / Cilt: 33 - Sayı: 3

Serum FGF-23 levels in predialysis chronic kidney disease are not associated with 25-OH D vitamin levels

Sayfa
195–200
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

For this reason it is of great importance to know the factors affecting the vitamin D levels in this patient group and to consider them in the treatment of the patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Vitamin D has been found to have effects on the neurolo-gical, immunological and endocrine systems in addition to its ef-fects on bone mineral metabolism.
📊
Temel Bulgular & Veri:Similar to the population in general , in patients with chronic kidney disease (CKD), vitamin D deficiency has been shown to be associated with progression of renal disease, increased cardiovascular mortality and morbidity.
💡
Sonuç & Katkı:For this reason it is of great importance to know the factors affecting the vitamin D levels in this patient group and to consider them in the treatment of the patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Vitamin D has been found to have effects on the neurolo-gical, immunological and endocrine systems in addition to its ef-fects on bone mineral metabolism. Similar to the population in general , in patients with chronic kidney disease (CKD), vitamin D deficiency has been shown to be associated with progression of renal disease, increased cardiovascular mortality and morbidity. In this study, we aimed to determine the factors affecting the vi-tamin D level in our CKD patients.Method: One hundred and twenty patients with CKD but not on dialysis who were admitted to our nephrology clinic were inclu-ded in the study. Results: Sixty-eight patients (56.7%) had vitamin D deficiency, 47 (39.2%) had vitamin D insufficiency. Sixty-eight patients had vitamin D levels of 56 pg/ml in 56 patients. Vita-min D levels in patients with, and without DM were 12.9±6.6 pg/ml and 16±8.1 pg/ml, respectively with a statistically significant intergroup difference (p<0.05). In univariate correlation analysis, vitamin D was negatively correlated with phosphorus (rs = -0.30, p<0.001), PTH (rs = -0.34, p<0.001), proteinuria (rs = -0.22) and DM (rs=-0.19, p<0.05), while positively correlated with hemoglo-bin (rs=0.27, p< 0.001). However we did not find any correlation between 25-OH-D and FGF 23 and (rs=-0.122, p=0.183), eGFR (p=0.183, rs=0.135). In multivariate linear regression analysis, only PTH (beta = -0.24, p<0.01) and glomerular filtration rate (beta = -0.215, p<0.05) were found to have a negative effect on vitamin D. Conclusion: In recent years, in addition to classical mineral meta-bolism of vitamin D, its pleotropic role and clinical consequences in predialysis CKD patients have been better understood. For this reason it is of great importance to know the factors affecting the vitamin D levels in this patient group and to consider them in the treatment of the patients.

🔖

Bu Makaleye Atıf Yap

KUZGUN, G. Ş., BASOK, B. I. (2018). Serum FGF-23 levels in predialysis chronic kidney disease are not associated with 25-OH D vitamin levels. Medeniyet Medical Journal, Cilt: 33 - Sayı: 3, 195–200. https://ajindex.com/articles/283281

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Holick MF. Vitamin D deficiency. Am N Engl J Med. 2007;357:266-81.
  2. Heaney RP. Vitamin D in health and disease. Am Clin J Am SocNephrol. 2008;3:1535-41.
  3. Cuppari L, Carvalho AB,Draibe SA. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr. 2008;18:408-14.
  4. Mehrotra R, Kermah D, Budoff M, et al. HypovitaminosisD in chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1144-51.
  5. Gonzalez EA, Sachdeva A, Oliver DA, Martin K.J. Vitamin D in-sufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004;24:503-10.
  6. Eknoyan G, Levin A, Levin N. K/DOQI clinical practice guideli-nes for bone metabolismand disease in chronic kidney disea-se. Am J Kidney Dis. 2003;42:S1-S201.
  7. Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009;75:88-95.
  8. Ishimura E, Nishizawa Y, Inaba M, et al. Serum levels of1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999;55:1019-27.
  9. Danzige J. The bone-renal axis in early chronic kidney di-sease: an emerging paradigm. Nephrol Dial Transplant. 2008;23:2733-7.
  10. Seiler S, Heine GH, Fliser D. Clinical relevance of FGF-23 in chronic Kidney disease. Kidney Int. 2009;76(Suppl14);534-42.
  11. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.
  12. Echida Y, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Risk fac-tors for vitamin D deficiency in patients with chronic kidney disease.Intern Med. 2012;51(8):845-50.
  13. Querfeld U. Vitamin D and inflammation.Pediatr Nephrol. 2013 Apr;28(4):605-10.
  14. Sasak G, Oral A, Bascı S. The relationship between vitamin D deficiency and increased mean platelet volume in renal transplant recipients. Med Med J. 2017;32(2):106-10
  15. Kendrick J, Targher G, Smit